WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis

Por Garimella, Sireesha V, Rocca, Andrea, Lipkowitz, Stanley
Publicado em 2011

Indigenous Hepatitis E Virus Genotype 1 Infection, Uruguay

Por Mirazo, Santiago, Mainardi, Victoria, Ramos, Natalia, Gerona, Solange, Rocca, Andrea, Arbiza, Juan
Publicado em 2014

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Por Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Publicado em 2006

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Por Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Publicado em 2006

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Por Rocca, Andrea, Schirone, Alessio, Maltoni, Roberta, Bravaccini, Sara, Cecconetto, Lorenzo, Farolfi, Alberto, Bronte, Giuseppe, Andreis, Daniele
Publicado no Ther Adv Med Oncol (2016)

A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel i...

Por Pietri, Elisabetta, Andreis, Daniele, Fabbri, Francesca, Menna, Cecilia, Schirone, Alessio, Kopf, Barbara, Rocca, Andrea, Amadori, Dino, De Giorgi, Ugo
Publicado no Oncologist (2015)

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

Por Orlando, Laura, Cardillo, Anna, Ghisini, Raffaella, Rocca, Andrea, Balduzzi, Alessandra, Torrisi, Rosalba, Peruzzotti, Giulia, Goldhirsch, Aron, Pietri, Elisabetta, Colleoni, Marco
Publicado em 2006

Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review

Por FAROLFI, ALBERTO, FERRARIO, CRISTIANO, AQUILINA, MICHELE, CECCONETTO, LORENZO, TARTAGLIA, ANDREAS, IBRAHIM, TONI, SERRA, LUIGI, OBOLDI, DEVIL, NIZZOLI, MAURIZIO, ROCCA, ANDREA
Publicado no Oncol Lett (2015)

Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer

Por Maltoni, Roberta, Casadio, Valentina, Ravaioli, Sara, Foca, Flavia, Tumedei, Maria Maddalena, Salvi, Samanta, Martignano, Filippo, Calistri, Daniele, Rocca, Andrea, Schirone, Alessio, Amadori, Dino, Bravaccini, Sara
Publicado no Oncotarget (2017)

Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study

Por MASSA, ILARIA, NANNI, ORIANA, GUIDOBONI, MASSIMO, FRASSINETI, GIOVANNI LUCA, ROCCA, ANDREA, BURGIO, MARCO ANGELO, VALMORRI, LINDA, MARRI, MATTIA, PIANCASTELLI, ALESSANDRA, FAEDI, MARINA, LEONI, MAURIZIO, TAMBERI, STEFANO, ALTINI, MATTIA, AMADORI, DINO
Publicado no Oncol Lett (2016)

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breas...

Por Catania, Chiara, Maur, Michela, Berardi, Rossana, Rocca, Andrea, Giacomo, Anna Maria Di, Spitaleri, Gianluca, Masini, Cristina, Pierantoni, Chiara, González-Iglesias, Reinerio, Zigon, Giulia, Tasciotti, Annaelisa, Giovannoni, Leonardo, Lovato, Valeria, Elia, Giuliano, Menssen, Hans D, Neri, Dario, Cascinu, Stefano, Conte, Pier Franco, de Braud, Filippo
Publicado no Cell Adh Migr (2015)